Suppr超能文献

抗磷脂抗体类型、同种型和滴度之间的关系:抗磷脂综合征临床试验和国际网络联盟(APS ACTION)研究。

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.

机构信息

Division of Rheumatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts.

University of Texas Medical Branch, Galveston, Texas.

出版信息

Lab Invest. 2023 Jun;103(6):100147. doi: 10.1016/j.labinv.2023.100147. Epub 2023 Apr 11.

Abstract

Several antiphospholipid antibody (aPL) profiles ("triple" and lupus anticoagulant [LA] positivity) are associated with a higher risk for clinical manifestations of antiphospholipid syndrome (APS). Further risk is correlated with higher levels of anticardiolipin antibody (aCL) and anti-β glycoprotein-I antibody (aβGPI), and with aPL persistence. Given that the 3 aPL tests detect partially overlapping sets of antibodies, the primary goal of this study was to characterize the associations among aPL tests using AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) core laboratory data. The APS ACTION Registry includes annually followed adult patients with positive aPL based on the Revised Sapporo Classification Criteria. We analyzed baseline and prospective core laboratory data of the registry for associations among aPL tests using the Spearman rank correlation with Bonferroni-adjusted significance level for multiple comparisons. An aPL Load was calculated based on 6 tests (aCL IgG/IgM/IgA and aβGPI IgG/IgM/IgA); a receiver operating characteristic curve was used to evaluate the diagnostic performance of the aPL Load in predicting LA positivity. In 351 patients simultaneously tested for LA, aCL, and aβGPI, the frequency of moderate-to-high (≥40 U) titers of aCL and aβGPI IgG/IgM/IgA was higher in patients who were positive for LA vs those who were negative. An aPL Load was calculated for each patient to assess the overall aPL burden. For every 1-point increase in the aPL Load, the possibility of a positive LA test increased by 32% (odds ratio, 1.32; 95% CI, 1.2-1.5; P < .001). Based on core laboratory data from a large international registry, most aPL enzyme-linked immunosorbent assay ≥40 U and a high calculated aPL Load combining 6 aPL enzyme-linked immunosorbent assays were predictive of a positive LA. These data suggest that the combined quantitative burden of aPL may provide a mechanistic explanation of a positive LA.

摘要

几种抗磷脂抗体(aPL)谱(“三重”和狼疮抗凝剂[LA]阳性)与抗磷脂综合征(APS)临床表现的更高风险相关。进一步的风险与更高水平的抗心磷脂抗体(aCL)和抗-β糖蛋白-I 抗体(aβGPI)以及 aPL 持续存在相关。鉴于这 3 种 aPL 检测方法检测到部分重叠的抗体组,本研究的主要目标是使用抗磷脂综合征临床试验和国际网络(APS ACTION)核心实验室数据来描述 aPL 检测之间的关联。APS ACTION 登记册包括根据修订后的 Sapporo 分类标准,每年随访基于阳性 aPL 的成年患者。我们使用 Spearman 秩相关分析和多重比较的 Bonferroni 校正显著性水平,分析登记册中 aPL 检测之间的关联的基线和前瞻性核心实验室数据。基于 6 项检测(aCL IgG/IgM/IgA 和 aβGPI IgG/IgM/IgA)计算了 aPL 负荷;使用受试者工作特征曲线评估 aPL 负荷预测 LA 阳性的诊断性能。在 351 例同时检测 LA、aCL 和 aβGPI 的患者中,LA 阳性患者的中高(≥40 U)滴度 aCL 和 aβGPI IgG/IgM/IgA 的频率高于 LA 阴性患者。为每位患者计算了 aPL 负荷,以评估整体 aPL 负担。aPL 负荷每增加 1 分,LA 检测阳性的可能性增加 32%(优势比,1.32;95%CI,1.2-1.5;P<.001)。基于大型国际登记处的核心实验室数据,大多数 aPL 酶联免疫吸附试验≥40 U 和高计算 aPL 负荷(结合 6 种 aPL 酶联免疫吸附试验)可预测 LA 阳性。这些数据表明,aPL 的联合定量负担可能提供 LA 阳性的机制解释。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验